Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Unknown 3

Sponsor Class

OTHER 8458INDUSTRY 2599NIH 444OTHER_GOV 251NETWORK 237UNKNOWN 49FED 14INDIV 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 12Lymphoid 4Gynecologic 3Breast 3Tumor-Agnostic 2Thoracic 2Sarcoma 2Plasma cell 2CNS 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 3Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1

Interventions

olaparib 1PM 01183 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDIV × Interventional × Breast × Clear all
NCT02684318 2017-06-22

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

Poveda, Andrés, M.D.

Phase 1/2 Unknown
100 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT01379092 2012-03-16

An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging

Levine, Gary M. , M.D.

Phase NA Unknown
100 enrolled
Breast

Breast Neoplasms

NCT00378638 2007-10-24

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Chap, Linnea I., M.D.

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡